Abstract:Objective:To evaluate the relationship of activated c-Src non-receptor tyrosine kinase with the clinicopathological features and prognosis of gastric cancer.Methods:Immunohistochemical staining(EnvisionTM) was used to detect activated c-Src non-receptor tyrosine kinase(p-SrcY419) in 123 gastric cancer tissues,adjacent non-tumorous tissues,and 8 normal gastric tissues.The association between p-Src(Y419) expression and the clinicopathological features was analyzed.Results:The expression rate of p-Src(Y419) significantly higher in gastric cancer tissues(60.4%) than in adjacent non-tumorous tissues(38%) and normal gastric tissues(14.2%).The P-Src(Y419) staining intensity was significantly related with the tumor size,tumor differentiation,and Lauren classification(P<0.05).The P-Src(Y419) staining extent and multiplier scores of the extent and intensity of p-Src(Y419) staining were all associated with the tumor size,tumor differentiation, depth of invasion,and pTNM classification.Multivariate analysis revealed that tumor differentiation was an independent factor for the positive expression of p-Src(Y419).Univariate survival analysis revealed a significant association of the two-year survival time with the p-Src(Y419) staining intensity,p-Src(Y419) staining extent,as well as multiplier scores of the extent and intensity of p-Src(Y419).Multivariate analysis revealed that elevated p-Src(Y419) staining intensity was an independent poor prognostic parameter for the two-year survival time. Conclusion:The specific activity of the non-receptor protein tyrosine kinase c-Src is increased in gastric cancer tissues compared with adjacent non-tumorous tissues and normal gastric tissues.Increased c-Src activity is significantly correlated with the tumor size,tumor differentiation,Lauren classification,depth of invasion and pTNM classification.c-Src activity can be used as an independent prognostic indicator.Src kinase inhibitor may be a new effective drug for gastric cancer treatment after Herceptin.

Relationship of Activated c-Src Kinase with the Clinicopathological Features and Prognosis of Gastric Cancer